These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20117291)

  • 1. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.
    Thotala DK; Geng L; Dickey AK; Hallahan DE; Yazlovitskaya EM
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):557-65. PubMed ID: 20117291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A GSK-3β inhibitor protects against radiation necrosis in mouse brain.
    Jiang X; Perez-Torres CJ; Thotala D; Engelbach JA; Yuan L; Cates J; Gao F; Drzymala RE; Rich KM; Schmidt RE; Ackerman JJ; Hallahan DE; Garbow JR
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):714-21. PubMed ID: 24969790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenticular mitoprotection. Part B: GSK-3β and regulation of mitochondrial permeability transition for lens epithelial cells in atmospheric oxygen.
    Brooks MM; Neelam S; Cammarata PR
    Mol Vis; 2013; 19():2451-67. PubMed ID: 24319338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.
    Li B; Zhang C; He F; Liu W; Yang Y; Liu H; Liu X; Wang J; Zhang L; Deng B; Gao F; Cui J; Liu C; Cai J
    Cell Physiol Biochem; 2013; 32(6):1720-8. PubMed ID: 24356466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
    Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
    J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenticular mitoprotection. Part A: Monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3β inhibitor, SB216763.
    Brooks MM; Neelam S; Fudala R; Gryczynski I; Cammarata PR
    Mol Vis; 2013; 19():1406-12. PubMed ID: 23825920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice.
    Lee CL; Lento WE; Castle KD; Chao NJ; Kirsch DG
    Radiat Res; 2014 May; 181(5):445-51. PubMed ID: 24720754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
    Thotala DK; Hallahan DE; Yazlovitskaya EM
    Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
    Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
    Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells.
    Jaeger A; Baake J; Weiss DG; Kriehuber R
    Int J Dev Neurosci; 2013 Feb; 31(1):61-8. PubMed ID: 23085082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
    Kaga S; Zhan L; Altaf E; Maulik N
    J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
    Neelam S; Brooks MM; Cammarata PR
    Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting glycogen synthase kinase 3beta in sepsis.
    Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala E; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
    Novartis Found Symp; 2007; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
    Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
    Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
    Wu W; Liu X; Han L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway.
    Thotala DK; Hallahan DE; Yazlovitskaya EM
    Cell Death Differ; 2012 Mar; 19(3):387-96. PubMed ID: 21738215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.
    Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala EM; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
    Crit Care Med; 2005 Sep; 33(9):1903-12. PubMed ID: 16148458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.